Compare MCRB & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCRB | MGYR |
|---|---|---|
| Founded | 2010 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.7M | 115.2M |
| IPO Year | 2015 | 2021 |
| Metric | MCRB | MGYR |
|---|---|---|
| Price | $9.42 | $17.92 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.33 | N/A |
| AVG Volume (30 Days) | ★ 46.0K | 8.0K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | N/A | ★ 26.83 |
| EPS | ★ 0.64 | 0.50 |
| Revenue | ★ $789,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $14.28 | $35.84 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $13.52 |
| 52 Week High | $29.98 | $20.00 |
| Indicator | MCRB | MGYR |
|---|---|---|
| Relative Strength Index (RSI) | 43.72 | 55.05 |
| Support Level | $6.99 | $17.07 |
| Resistance Level | $9.60 | $18.96 |
| Average True Range (ATR) | 0.53 | 0.37 |
| MACD | 0.24 | -0.01 |
| Stochastic Oscillator | 77.57 | 67.48 |
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.